Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma
Open Access
- 10 October 2001
- Vol. 92 (8), 2181-2189
- https://doi.org/10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3
Abstract
BACKGROUND In some malignancies, p53 mutations are associated with tumor progression. To address the role of p53 mutations in the development and progression of osteosarcoma, the authors analyzed specimens from 247 patients with primary localized osteosarcomas and 25 patients with osteosarcomas that were metastatic at the time of diagnosis. The group included 27 matched biopsy‐resection specimens and 21 biopsy‐metastasis paired specimens. METHODS The authors examined the nature and location of p53 mutations (exons 4–10) by polymerase chain reaction–single‐strand conformation polymorphism and confirmed mutations by direct DNA sequencing. RESULTS The overall frequency of p53 mutations was 22% (60 of 272 specimens), with 13 of 60 mutations located in exons 4 or 10. A similar proportion of localized osteosarcomas had alterations of the p53 gene (55 of 247 specimens; 22.3%) compared with tumors from patients who had metastases at the time of diagnosis (5 of 25 specimens; 20%; P = 0.96). Patients who had p53 missense mutations were older compared with patients who had nonsense alterations or a wild type gene (P = 0.01). Examination of paired biopsy‐resection and biopsy‐metastasis specimens revealed that the p53 status was concordant between the biopsy and later tumor specimens in all patients. CONCLUSIONS The p53 mutation status did not differentiate between patients who presented with a localized osteosarcoma and those who presented with metastases at the time of diagnosis. The current data indicate that p53 mutations are not late events in osteosarcoma tumor progression, because they are evident before the development of metastases. The inclusion of exons 4 and 10 increased the sensitivity of the analysis. Cancer 2001;92:2181–9. © 2001 American Cancer Society.Keywords
This publication has 37 references indexed in Scilit:
- Osteosarcoma of the Extremities with Synchronous Lung Metastases: Long-Term Results in 44 Patients Treated with Neoadjuvant ChemotherapyJournal of Chemotherapy, 1998
- Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma IntergroupThe Lancet, 1997
- The status of p53 in the metastatic progression of colorectal cancerEuropean Journal Of Cancer, 1997
- Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.Journal of Clinical Oncology, 1997
- Synchronous multifocal osteosarcoma: Results in twelve patients treated with neoadjuvant chemotherapy and simultaneous resection of all involved bonesAnnals of Oncology, 1996
- Prognostic factors in osteosarcoma: a critical review.Journal of Clinical Oncology, 1994
- Colorectal Cancer and the Intersection between Basic and Clinical ResearchCold Spring Harbor Symposia on Quantitative Biology, 1994
- Osteogenic sarcoma with clinically detectable metastasis at initial presentation.Journal of Clinical Oncology, 1993
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986